CoChat
Sign Up
Cited by 2,429Atherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular HealthInflammatory Biomarkers in Disease Prognosis

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

Open access
Ridker, Paul M., Rifai, Nader, Stampfer, Meir J., Hennekens, Charles H.·2000·Circulation
DOI 10.1161/01.cir.101.15.1767
Open this paper in CoChat — free account

Abstract

Background —Interleukin-6 (IL-6) plays a central role in inflammation and tissue injury. However, epidemiological data evaluating the role of IL-6 in atherogenesis are sparse. Methods and Results —In a prospective study involving 14 916 apparently healthy men, we measured baseline plasma concentration of IL-6 in 202 participants who subsequently developed myocardial infarction (MI) and in 202 study participants matched for age and smoking status who did not report vascular disease during a 6-year follow-up. Median concentrations of IL-6 at baseline were higher among men who subsequently had an MI than among those who did not (1.81 versus 1.46 pg/mL; P =0.002). The risk of future MI increased with increasing quartiles of baseline IL-6 concentration ( P for trend <0.001) such that men in the highest quartile at entry had a relative risk 2.3 times higher than those in the lowest quartile (95% CI 1.3 to 4.3, P =0.005); for each quartile increase in IL-6, there was a 38% increase in risk ( P =0.001).This relationship remained significant after adjustment for other cardiovascular risk factors, was stable over long periods of follow-up, and was present in all low-risk subgroups, including nonsmokers. Although the strongest correlate of IL-6 in these data was C-reactive protein ( r =0.43, P <0.001), the relationship of IL-6 with subsequent risk remained after control for this factor ( P <0.001). Conclusions —In apparently healthy men, elevated levels of IL-6 are associated with increased risk of future MI. These data thus support a role for cytokine-mediated inflammation in the early stages of atherogenesis.

Overview

Integrity signals

Registry

Crossref · 10.1161/01.cir.101.15.1767

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Research works printed but not linked: 12

  1. 10.1182/blood.V76.12.2520.2520 · DOI
  2. 10.1161/circ.98.8.731 · DOI
  3. 10.1161/atvb.17.6.1121 · DOI
  4. 10.1161/circ.94.5.874 · DOI
  5. 10.1161/circ.99.16.2079 · DOI
  6. 10.1161/circ.98.22.2370 · DOI
  7. 10.1161/circ.91.11.2844 · DOI
  8. 10.1161/circ.95.7.1777 · DOI
  9. 10.1161/circ.100.8.793 · DOI
  10. 10.1161/circ.96.11.4095 · DOI
  11. 10.1161/circ.98.25.2796 · DOI
  12. 10.1161/circ.99.9.1161 · DOI

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H.
Affiliations
Brigham and Women's Hospital (US)
ORCID
Venue
Circulation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2000-04-18
Volume
101
Issue
15
Pages
1767-1772
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
DOI
10.1161/01.cir.101.15.1767
OpenAlex
W2067504868
Cited by
2,429
References
40
Citations by year
2026: 41 · 2025: 48 · 2024: 55 · 2023: 56 · 2022: 57 · 2021: 74 · 2020: 64 · 2019: 64 · 2018: 82 · 2017: 85 · 2016: 96 · 2015: 99 · 2014: 118 · 2013: 101 · 2012: 107
FWCI
33.08
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • American Heart Association
  • National Heart, Lung, and Blood Institute (R01HL058755, HL-58755)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords
interleukin-6, myocardial infarction, atherogenesis, inflammation, cytokines, C-reactive protein, cardiovascular risk, healthy men, plasma cytokine concentrations
MeSH terms
C-Reactive Protein, Coronary Artery Disease, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors, Smoking, Interleukin-6, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review